163 related articles for article (PubMed ID: 1311062)
21. An intact PDGF signaling pathway is required for efficient growth transformation of mouse C127 cells by the bovine papillomavirus E5 protein.
Riese DJ; DiMaio D
Oncogene; 1995 Apr; 10(7):1431-9. PubMed ID: 7731695
[TBL] [Abstract][Full Text] [Related]
22. Anchorage-independent growth of v-myc-transformed Balb/c 3T3 cells is promoted by platelet-derived growth factor or co-transformation by other oncogenes.
Vennström B; Bravo R
Oncogene; 1987; 1(3):271-6. PubMed ID: 3330775
[TBL] [Abstract][Full Text] [Related]
23. Growth-regulating functions of human papillomavirus early gene products in cervical cancer cells acting dominant over enhanced epidermal growth factor receptor expression.
von Knebel Doeberitz M; Gissmann L; zur Hausen H
Cancer Res; 1990 Jun; 50(12):3730-6. PubMed ID: 1692767
[TBL] [Abstract][Full Text] [Related]
24. Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: an in vitro multistep carcinogenesis model.
Park NH; Gujuluva CN; Baek JH; Cherrick HM; Shin KH; Min BM
Oncogene; 1995 Jun; 10(11):2145-53. PubMed ID: 7784058
[TBL] [Abstract][Full Text] [Related]
25. Growth in culture and tumorigenicity after transfection with the ras oncogene of liver epithelial cells from carcinogen-treated rats.
Braun L; Goyette M; Yaswen P; Thompson NL; Fausto N
Cancer Res; 1987 Aug; 47(15):4116-24. PubMed ID: 2440558
[TBL] [Abstract][Full Text] [Related]
26. [Effects of human papillomavirus 16 E5 on malignancy of human cervical cancer cells and the mechanism there of].
Liao SJ; Deng DR; Xia X
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(43):3080-4. PubMed ID: 19192411
[TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
[TBL] [Abstract][Full Text] [Related]
28. Cell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformation.
Araujo JC; Doniger J; Stöppler H; Sadaie MR; Rosenthal LJ
Oncogene; 1997 Feb; 14(8):937-43. PubMed ID: 9050993
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
[TBL] [Abstract][Full Text] [Related]
30. Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor beta 1.
Braun L; Dürst M; Mikumo R; Gruppuso P
Cancer Res; 1990 Nov; 50(22):7324-32. PubMed ID: 2171761
[TBL] [Abstract][Full Text] [Related]
31. Effect of glucocorticoid hormones on viral gene expression, growth, and dysplastic differentiation in HPV16-immortalized ectocervical cells.
Khare S; Pater MM; Tang SC; Pater A
Exp Cell Res; 1997 May; 232(2):353-60. PubMed ID: 9168812
[TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factor-1 (IGF-1), insulin, and epidermal growth factor (EGF) are survival factors for density-inhibited, quiescent Balb/c-3T3 murine fibroblasts.
Tamm I; Kikuchi T
J Cell Physiol; 1990 Jun; 143(3):494-500. PubMed ID: 2193035
[TBL] [Abstract][Full Text] [Related]
33. Cotransfection of HPV-18 and v-fos DNA induces tumorigenicity of primary human keratinocytes.
Pei XF; Meck JM; Greenhalgh D; Schlegel R
Virology; 1993 Oct; 196(2):855-60. PubMed ID: 8396813
[TBL] [Abstract][Full Text] [Related]
34. The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells.
Hwang ES; Nottoli T; Dimaio D
Virology; 1995 Aug; 211(1):227-33. PubMed ID: 7645215
[TBL] [Abstract][Full Text] [Related]
35. Imbalanced expression of cellular nuclear oncogenes caused by v-sis/PDGF-2.
Sonobe MH; Bravo R; Armelin MS
Oncogene; 1991 Sep; 6(9):1531-7. PubMed ID: 1923519
[TBL] [Abstract][Full Text] [Related]
36. The human papillomavirus (HPV)-6 and HPV-16 E5 proteins co-operate with HPV-16 E7 in the transformation of primary rodent cells.
Valle GF; Banks L
J Gen Virol; 1995 May; 76 ( Pt 5)():1239-45. PubMed ID: 7730808
[TBL] [Abstract][Full Text] [Related]
37. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes.
Straight SW; Hinkle PM; Jewers RJ; McCance DJ
J Virol; 1993 Aug; 67(8):4521-32. PubMed ID: 8392596
[TBL] [Abstract][Full Text] [Related]
38. Effect of human papillomavirus type 16 oncogenes on MAP kinase activity.
Gu Z; Matlashewski G
J Virol; 1995 Dec; 69(12):8051-6. PubMed ID: 7494320
[TBL] [Abstract][Full Text] [Related]
39. The E5 gene product of rhesus papillomavirus is an activator of endogenous Ras and phosphatidylinositol-3'-kinase in NIH 3T3 cells.
Ghai J; Ostrow RS; Tolar J; McGlennen RC; Lemke TD; Tobolt D; Liu Z; Faras AJ
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12879-84. PubMed ID: 8917513
[TBL] [Abstract][Full Text] [Related]
40. Analysis of human papillomavirus type 16 E5 oncogene expression in vitro and from bicistronic messenger RNAs.
Johnsen CK; Stanley M; Norrild B
Intervirology; 1995; 38(6):339-45. PubMed ID: 8880384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
